Discovery of potent and use-dependent sodium channel blockers for treatment of chronic pain.

[1]  A. Cowan,et al.  Standardization of the rat paw formalin test for the evaluation of analgesics , 2005, Psychopharmacology.

[2]  V. Warren,et al.  A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model. , 2004, Biochemistry.

[3]  V. Warren,et al.  Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. , 2004, Assay and drug development technologies.

[4]  Tonhu Vu.  Current pharmacologic approaches to treating neuropathic pain , 2004, Current pain and headache reports.

[5]  J. Hunter,et al.  The role of voltage-gated sodium channels in neuropathic pain , 2003, Current Opinion in Neurobiology.

[6]  Hao Wang,et al.  Functional and pharmacological properties of canine ERG potassium channels. , 2003, American journal of physiology. Heart and circulatory physiology.

[7]  S. Schug.  Mechanisms and Mediators of Neuropathic Pain , 2002 .

[8]  A. Cavalli,et al.  Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. , 2002, Journal of medicinal chemistry.

[9]  M. Gold,et al.  Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8 , 2002, Pain.

[10]  D Le Bars,et al.  Animal models of nociception. , 2001, Pharmacological reviews.

[11]  T. Jensen,et al.  The clinical picture of neuropathic pain. , 2001, European journal of pharmacology.

[12]  A. Basbaum,et al.  Molecular mechanisms of nociception , 2001, Nature.

[13]  S. Nesnow,et al.  An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naphtho[2,1-d]thiophene. , 2001, Chemical research in toxicology.

[14]  D. Madge,et al.  Medicinal chemistry of neuronal voltage-gated sodium channel blockers. , 2001, Journal of medicinal chemistry.

[15]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Dib-Hajj,et al.  Changes in Expression of Two Tetrodotoxin-Resistant Sodium Channels and Their Currents in Dorsal Root Ganglion Neurons after Sciatic Nerve Injury But Not Rhizotomy , 2000, The Journal of Neuroscience.

[17]  J. Mao,et al.  Systemic lidocaine for neuropathic pain relief , 2000, Pain.

[18]  L. Overman,et al.  A new strategy for synthesis of attached rings , 2000 .

[19]  W. Catterall,et al.  From Ionic Currents to Molecular Mechanisms The Structure and Function of Voltage-Gated Sodium Channels , 2000, Neuron.

[20]  T. Yaksh.  Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. , 1999, Trends in pharmacological sciences.

[21]  L. Overman,et al.  Stereocontrolled Synthesis of Trisubstituted Tetrahydropyrans , 1999 .

[22]  C. Bountra,et al.  Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons , 1998, Nature Neuroscience.

[23]  E. Kalso,et al.  Systemic local‐anaesthetic‐type drugs in chronic pain: A systematic review , 1998, European journal of pain.

[24]  S. Halegoua,et al.  Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Mansuy,et al.  Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo. , 1996, Chemical research in toxicology.

[26]  R. Eglen,et al.  Structure and Function of a Novel Voltage-gated, Tetrodotoxin-resistant Sodium Channel Specific to Sensory Neurons (*) , 1996, The Journal of Biological Chemistry.

[27]  L. Sivilotti,et al.  A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons , 1996, Nature.

[28]  D. Mansuy,et al.  New Biological Reactive Intermediates , 1996 .

[29]  D. Mansuy,et al.  New biological reactive intermediates: metabolic activation of thiophene derivatives. , 1996, Advances in experimental medicine and biology.

[30]  S. Ito,et al.  1,1′-(azodicarbonyl)dipiperidine-tributylphosphine, a new reagent system for mitsunobu reaction , 1993 .

[31]  F. Porreca,et al.  The rat paw formalin test: comparison of noxious agents , 1990, Pain.

[32]  O. Mitsunobu.  The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products , 1981 .